HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiao Niu Selected Research

Aluminum

10/2022Aluminum Induced Necroptosis of PC12 Cells via TNFR1-RIP1/RIP3 Signalling Pathway.
9/2022Deferoxamine ameliorated Al(mal)3-induced neuronal ferroptosis in adult rats by chelating brain iron to attenuate oxidative damage.
2/2022Necrostatin-1 Relieves Learning and Memory Deficits in a Zebrafish Model of Alzheimer's Disease Induced by Aluminum.
1/2022The association between blood lymphocyte NMDAR, group I mGluRs and cognitive function changes in occupationally aluminum-exposed workers and verification in rats.
1/2022Aluminum inhibits non-amyloid pathways via retinoic acid receptor.
1/2022Blood pressure mediated the effects of cognitive function impairment related to aluminum exposure in Chinese aluminum smelting workers.
12/2021Whole-transcriptome analysis of aluminum-exposed rat hippocampus and identification of ceRNA networks to investigate neurotoxicity of Al.
12/2021The Role of PKC in Regulating NMDARs in Aluminum-Induced Learning and Memory Impairment in Rats.
8/2021miR-29a and the PTEN-GSK3β axis are involved in aluminum-induced damage to primary hippocampal neuronal networks.
6/2021Regulation of mGluR1 on the Expression of PKC and NMDAR in Aluminum-Exposed PC12 Cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiao Niu Research Topics

Disease

16Cognitive Dysfunction
09/2022 - 02/2013
14Alzheimer Disease (Alzheimer's Disease)
09/2022 - 01/2012
6Necrosis
10/2022 - 03/2010
6Neurodegenerative Diseases (Neurodegenerative Disease)
05/2021 - 02/2008
5Memory Disorders (Memory Loss)
02/2022 - 10/2013
5Body Weight (Weight, Body)
07/2014 - 01/2004
3Brain Diseases (Brain Disorder)
12/2007 - 04/2003
2Neoplasms (Cancer)
04/2021 - 01/2015
2Pheochromocytoma
01/2021 - 10/2013
2Dementia (Dementias)
04/2020 - 01/2019
1Hypertension (High Blood Pressure)
01/2022
1Wounds and Injuries (Trauma)
08/2021
1Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy)
08/2019
1Vascular Diseases (Vascular Disease)
01/2019
1Epilepsy (Aura)
01/2019
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2019
1Birth Weight (Birth Weights)
12/2018
1Hypersensitivity (Allergy)
11/2017
1Congenital Abnormalities (Deformity)
01/2017
1Amyloid Plaque
07/2014
1Arsenic Poisoning
03/2014
1Neuroblastoma
04/2010
1Chronic Hepatitis B
10/2009
1Glioma (Gliomas)
05/2008
1Edema (Dropsy)
04/2006
1Neural Tube Defects (Exencephaly)
11/2004

Drug/Important Bio-Agent (IBA)

29AluminumIBA
10/2022 - 05/2008
7Proteins (Proteins, Gene)FDA Link
10/2022 - 03/2014
5Small Interfering RNA (siRNA)IBA
10/2022 - 02/2008
3Aluminum Oxide (Sapphire)IBA
09/2022 - 10/2013
3necrostatin-1IBA
02/2022 - 04/2010
3tau Proteins (tau Protein)IBA
12/2021 - 11/2013
2Type I Tumor Necrosis Factor ReceptorsIBA
10/2022 - 09/2021
2Messenger RNA (mRNA)IBA
10/2022 - 03/2014
2ElementsIBA
09/2022 - 01/2021
2NMDA receptor A1IBA
01/2022 - 02/2007
2aluminum maltolateIBA
01/2021 - 08/2019
2CaspasesIBA
04/2020 - 01/2014
2SolventsIBA
10/2013 - 07/2013
2hexabrominated diphenyl ether 153IBA
07/2013 - 06/2013
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2007 - 02/2007
2Excitatory Amino AcidsIBA
02/2007 - 04/2003
1Phosphotransferases (Kinase)IBA
10/2022
1maltolIBA
10/2022
1IronIBA
09/2022
1NeurotoxinsIBA
12/2021
1LithiumIBA
05/2021
1ZincIBA
05/2021
1MetalsIBA
05/2021
1IonsIBA
05/2021
1Autophagy-Related ProteinsIBA
04/2021
1Saline SolutionIBA
04/2021
1Beclin-1IBA
04/2021
1Amyloid beta-PeptidesIBA
01/2021
1Biological ProductsIBA
08/2020
1Sirolimus (Rapamycin)FDA Link
08/2020
1benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
04/2020
1Therapeutic UsesIBA
04/2020
1histone H3 trimethyl Lys4IBA
10/2019
1MethyltransferasesIBA
10/2019
1Dynamins (Dynamin)IBA
08/2019
1Pharmaceutical PreparationsIBA
01/2019
1hydroxide ionIBA
12/2018
1AllergensIBA
11/2017
1VaccinesIBA
01/2015
1SincalideFDA Link
11/2014
1Amyloid (Amyloid Fibrils)IBA
07/2014
1CalpainIBA
03/2014
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
11/2013
1CarbonIBA
10/2013
1dimethyltinIBA
10/2013
1di-n-butyltin (dibutyltin)IBA
10/2013
1diphenyltinIBA
10/2013
1Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2013
1Olive OilIBA
07/2013
1Plant Oils (Vegetable Oils)IBA
06/2013
1Caspase 3 (Caspase-3)IBA
04/2010
1Aluminum ChlorideIBA
04/2010
1Annexin A5IBA
03/2010
1bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
03/2010
1lipoarabinomannan (LAM)IBA
10/2009
1Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2009
1Hepatitis B e AntigensIBA
10/2009
1Lamivudine (Epivir)FDA Link
10/2009
1DNA (Deoxyribonucleic Acid)IBA
10/2009
1bcl-2 Homologous Antagonist-Killer Protein (bcl 2 Homologous Antagonist Killer Protein)IBA
02/2008
1LanthanumIBA
04/2006
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2004
1IsoflavonesIBA
11/2004
1Folic Acid (Vitamin M)FDA LinkGeneric
11/2004
1Drinking WaterIBA
01/2004
1ethylene dichloride (1,2-dichloroethane)IBA
04/2003

Therapy/Procedure

2Intraperitoneal Injections
07/2014 - 07/2013
1Aftercare (After-Treatment)
10/2009